KR102901451B1 - 말초 혈류 장애의 치료제 - Google Patents

말초 혈류 장애의 치료제

Info

Publication number
KR102901451B1
KR102901451B1 KR1020217018397A KR20217018397A KR102901451B1 KR 102901451 B1 KR102901451 B1 KR 102901451B1 KR 1020217018397 A KR1020217018397 A KR 1020217018397A KR 20217018397 A KR20217018397 A KR 20217018397A KR 102901451 B1 KR102901451 B1 KR 102901451B1
Authority
KR
South Korea
Prior art keywords
cells
disease
cell
muse
peripheral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217018397A
Other languages
English (en)
Korean (ko)
Other versions
KR20210099014A (ko
Inventor
사토아키 마토바
마리 데자와
Original Assignee
교토후고리츠다이가쿠호진
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 교토후고리츠다이가쿠호진 filed Critical 교토후고리츠다이가쿠호진
Publication of KR20210099014A publication Critical patent/KR20210099014A/ko
Application granted granted Critical
Publication of KR102901451B1 publication Critical patent/KR102901451B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020217018397A 2018-11-30 2019-11-29 말초 혈류 장애의 치료제 Active KR102901451B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2018-225295 2018-11-30
JP2018225295 2018-11-30
PCT/JP2019/046847 WO2020111249A1 (ja) 2018-11-30 2019-11-29 末梢血流障害の治療剤

Publications (2)

Publication Number Publication Date
KR20210099014A KR20210099014A (ko) 2021-08-11
KR102901451B1 true KR102901451B1 (ko) 2025-12-16

Family

ID=70853028

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217018397A Active KR102901451B1 (ko) 2018-11-30 2019-11-29 말초 혈류 장애의 치료제

Country Status (9)

Country Link
US (1) US12611430B2 (https=)
EP (1) EP3888751B1 (https=)
JP (1) JP7473207B2 (https=)
KR (1) KR102901451B1 (https=)
CN (1) CN113195054A (https=)
AU (1) AU2019388016B2 (https=)
CA (1) CA3121444A1 (https=)
SG (1) SG11202105686UA (https=)
WO (1) WO2020111249A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007900A1 (ja) * 2009-07-15 2011-01-20 Dezawa Mari 生体組織から単離できる多能性幹細胞

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012024296A1 (en) * 2010-08-20 2012-02-23 University Of Miami Arterial repair with cultured bone marrow cells and whole bone marrow
CN102641297B (zh) * 2011-02-21 2016-02-24 杨子江 治疗外周动脉粥样硬化引起的缺血性疾病的制剂及其制备方法
EP3492091B1 (en) 2016-07-29 2021-07-14 Tohoku University "muse" cells as prophylactic or therapeutic agent for aneurysm

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007900A1 (ja) * 2009-07-15 2011-01-20 Dezawa Mari 生体組織から単離できる多能性幹細胞

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Matoba Satoaki, Therapeutic Angiogenesis for Peripheral Artery Disease, Journal of Kyoto Prefectural University of Medicine. 2016, vol. 126, no. 11, 759-767면*

Also Published As

Publication number Publication date
JP7473207B2 (ja) 2024-04-23
EP3888751B1 (en) 2024-04-17
US12611430B2 (en) 2026-04-28
WO2020111249A1 (ja) 2020-06-04
EP3888751C0 (en) 2024-04-17
EP3888751A4 (en) 2022-10-05
KR20210099014A (ko) 2021-08-11
AU2019388016A1 (en) 2021-07-08
SG11202105686UA (en) 2021-06-29
CN113195054A (zh) 2021-07-30
US20220000936A1 (en) 2022-01-06
EP3888751A1 (en) 2021-10-06
AU2019388016B2 (en) 2024-12-19
CA3121444A1 (en) 2020-06-04
JPWO2020111249A1 (https=) 2020-06-04

Similar Documents

Publication Publication Date Title
KR101730052B1 (ko) 심근경색의 수복 재생을 유도하는 다능성 간세포
JP5606008B2 (ja) 骨髄間質細胞及び間葉系幹細胞の培養方法、中枢神経系疾患治療用の移植細胞の製造方法
ES2846795T3 (es) Células madres pluripotentes para el tratamiento de la úlcera cutánea diabética
JP5845089B2 (ja) 肢虚血の治療
JP7029729B2 (ja) 血管障害の予防又は治療剤
KR102901451B1 (ko) 말초 혈류 장애의 치료제
JP7618233B2 (ja) 脳血管性認知症の治療または予防剤
JP2025123077A (ja) 脊髄梗塞治療のための多能性幹細胞
Fukuta et al. Synergistic effect of ex-vivo quality and quantity cultured mononuclear cells and mesenchymal stem cell therapy in ischemic hind limb model mice
WO2021045190A1 (ja) 心筋炎の治療剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)